MagicTouch SCB receives IDE approval for In-Stent Restenosis
The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch Sirolimus
Source: ryt9.com
Page 2 - Nanolute Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nanolute Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nanolute Technology Today - Breaking & Trending Today
TRANSFORM 1 enrollment completed: A crucial RCT ready to redefine the DCB Angioplasty Mechanism
Birmingham [England], September 14 (ANI/PRNewswire): Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch Sirolimus Coated Balloon). The Randomized Controlled Trial (RCT) was conceptualized with the aim of understanding how the treatment indications and applications of Drug-Coated Balloon (DCB) in coronary artery disease (CAD) can be broadened. This prospective, randomized, multi-centre, RCT focusing on small vessels, de-novo coronary lesion treatment enrolled the culminating 114th patient on...
Source: laosnews.net
Well Begun AND Half Done! - SIRONA Randomized Trial Achieves fifty percent enrollment
JENA, Germany, Feb. 9, 2022 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second stat...
Source: businessinsider.com
Well Begun AND Half Done! - SIRONA Randomized Trial Achieves fifty percent enrollment
/PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status update of SIRONA RCT (Head-to-Head...
Source: prnewswire.com
Well Begun AND Half Done! - SIRONA Randomized Trial Achieves fifty percent enrollment
JENA, Germany, Feb. 9, 2022 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status
Source: adnkronos.com